Figure 2. Cumulative Infection Incidence Among Matched Cohorts of BNT162b2-Vaccinated and mRNA-1273–Vaccinated Individuals With and Without Prior Infection.
aSee eFigure 2 in the Supplement for extended follow-up of the BNT162b2 cohort.
aSee eFigure 2 in the Supplement for extended follow-up of the BNT162b2 cohort.